New ways of using nicotine

A. Araujo (Rio De Janeiro (RJ), Brazil)

Source: International Congress 2019 – Spanish/Portuguese programme 2019: Part II
Session: Spanish/Portuguese programme 2019: Part II
Session type: Language session
Number: 177
Disease area: -

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Araujo (Rio De Janeiro (RJ), Brazil). New ways of using nicotine. International Congress 2019 – Spanish/Portuguese programme 2019: Part II

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New ways in respiratory genetics
Source: Eur Respir J 2006; 28: 1079-1080
Year: 2006


New and repurposed drugs
Source: Eur Respir Monogr 2018; 82: 179-204
Year: 2018


New smoking cessation products in the pipeline
Source: ERS Course 2015
Year: 2015




New twists in the pharmacology of NSAID drugs
Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment
Year: 2007


New targets for drug development in asthma
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008


New therapeutic targets
Source: Annual Congress 2007 - COPD – a disease of accelerated ageing?
Year: 2007


Understanding nicotine addiction and the health effects of nicotine use
Source: Eur Respir Monogr 2021; 90: 18-32
Year: 2021


New bronchodilators
Source: Annual Congress 2012 - The promise of new drugs for treating asthma and COPD
Year: 2012


What are kids experimenting with? Epidemiology and trends of tobacco use and mental effects of nicotine and cannabis use
Source: Virtual Congress 2021 – Orphan childhood disease: nicotine and cannabis addiction
Year: 2021


New drugs for severe asthma – what should we target and how?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014


New therapeutic strategies in BOS
Source: Annual Congress 2007 - Bronchiolitis obliterans syndrome (BOS) after lung transplantation: new kids on the block
Year: 2007


New Drugs for COPD: the current status
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014


New pathways, new targets 
Source: International Congress 2017 – Lung cancer immunotherapy
Year: 2017


New possibilities in exposure assessment for microbial agents
Source: ERS Research Seminar 2015
Year: 2015


New frontiers in the management of asthma
Source: International Congress 2017 – State of the art session: "Paediatric"
Year: 2017